NCT03429959

Brief Summary

The investigators aim to evaluate the user friendliness of a newly designed leg compression stocking kit, the SOCKNLEG, compared to a standard leg compression stocking of the same compression strength, the SIGVARIS Cotton. The SOCKNLEG is not yet commercially available, whereas the SIGVARIS Cotton has been successfully commercialized for many years. After an initial screening visit, a computer generated list will allocate the participants in either the SOCKNLEG or the SIGVARIS Cotton group. All participants will try on both study stockings, in the order of their allocated group, and will rate their donning and doffing success with a questionnaire. The patients will then wear only the assigned study stocking of their allocated group, for a day and rate its comfort again at the end of the day. The donning and doffing success will also be rated by the study investigator. Leg volume measurements of the study leg will be taken at each visit to determine edema prevention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2017

Completed
26 days until next milestone

Study Start

First participant enrolled

January 10, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 12, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2018

Completed
Last Updated

June 27, 2019

Status Verified

June 1, 2019

Enrollment Period

6 months

First QC Date

December 15, 2017

Last Update Submit

June 26, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of patients who completely don the two investigated leg compression devices

    through study completion, within 7 months

Secondary Outcomes (4)

  • Number of patients who completely doff the two investigated leg compression devices

    through study completion, within 7 months

  • Patient evaluation of user friendliness

    3 days

  • Measuring oedema prevention of the compression stockings by comparison of leg volume measurement at V4 to V3 and V4 to V2.

    3 days

  • Time needed to don and doff the two investigated leg compression

    3 days

Study Arms (2)

SOCKNLEG

EXPERIMENTAL

Donning and doffing success of the study stocking compared with both stockings, wearing of the study stocking for a day, standardized non invasive measurement to calculate leg volume of the study leg

Device: SOCKNLEG

SIGVARIS Cotton

ACTIVE COMPARATOR

Donning and doffing success of the study stocking compared with both stockings, wearing of the study stocking for a day, standardized non invasive measurement to calculate leg volume of the study leg

Device: SIGVARIS Cotton

Interventions

SOCKNLEGDEVICE

Donning and doffing success compared with the two study stockings, wearing the assigned study stocking for a day, Patient Quesationnaire on donning and doffing success and wearing comfort of each study stocking

SOCKNLEG

SIGVARIS Cotton

SIGVARIS Cotton

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Informed Consent as documented by signature
  • Male or postmenopausal female patient, aged over 65 years of age
  • Diagnosed venous insufficiency stage C3-C6 (according to CEAP (Clinical, Etiologic, Anatomic, Pathophysiologic) -classification for venous diseases)

You may not qualify if:

  • Venous leg ulcer with a surface \>5cm2
  • Peripheral artery disease (PAD) or media calcinosis (Ankle-Brachial-Index \<0.8 or \>1.3)
  • Difference in brachial blood pressure \>20mmHg in both arms
  • Suspected polyneuropathy with ≥4 sensible test areas, measured with the Semmes-Weinstein-Monofilament-Test
  • Inability to reach the forefoot with their hands
  • Inability to follow the procedures of the study
  • Bed-ridden hospitalized patients who are not able to leave the bed or sit upright for a few consecutive hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Dermatology, University Hospital of Zurich, Switzerland

Zurich, CH-8091, Switzerland

Location

Study Officials

  • Juerg Hafner, Prof.

    Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2017

First Posted

February 12, 2018

Study Start

January 10, 2018

Primary Completion

June 30, 2018

Study Completion

June 30, 2018

Last Updated

June 27, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations